About Hematologics Inc.

Hematologics, Inc., a diagnostic service laboratory established in 1995, is built on a long history of research. Its principals and staff, who have decades of training and experience, invented many of the techniques that are now standard in the field:

About Hemotologics

  • Over 30 years experience in flow cytometry, starting with the first FACS instrument at Stanford in 1973 [1-3]
  • Invented multi-color immunofluorescence and multi-angle light scatter [4-6]
  • Described the antigenic patterns expressed during normal hematopoietic cell development and defined both lineage and maturation of cells in erythroid, myeloid and lymphoid lineages [7-18]
  • Identified human progenitor cells and the hematopoietic stem cell [19-23]
  • Developed correction for blood contamination of bone marrow specimens [24]
  • Developed techniques, including CD45 vs. SSC (right angle light scatter) gating for separation of distinct populations in bone marrow [13, 25-28]
  • Showed that tumors express normal antigens in abnormal relationships, allowing the detection of residual leukemia based on “difference from normal” [30-33]
  • Developed and fine tuned techniques for minimal disease detection even in the absence of a diagnostic specimen [34-39]
  • Advanced the use of flow cytometry for diagnosis and determination of prognostic outcome in MDS [40-46]
  • Pioneered the use of cell sorting in confirmation of minimal residual disease [39, 46-48]
Hematologics, Inc. combines unique expertise in multi-dimensional flow cytometry, tumor cell sorting, cytogenetics and molecular genetics with a broad understanding of hematopoiesis and clinical knowledge to provide you with the information you need. Our Retrospect DNA Archiving™ service offers yet one more approach for monitoring your patient for residual disease and determination of relapse.

This is a unique website which will require a more modern browser to work!

Please upgrade today!